I believe the advancements in tooth regeneration will eventually disrupt the traditional dental industry, leading to significant gains for companies i...
Read
More
I believe the advancements in tooth regeneration will eventually disrupt the traditional dental industry, leading to significant gains for companies in this space like Dentsply. With human testing already underway and the potential market shift, getting in now seems like a smart move for the long-term investor.
Given the ongoing securities class action lawsuits and negative press surrounding Dentsply Sirona’s Byte aligners, I believe there is a significant ri...
Read
More
Given the ongoing securities class action lawsuits and negative press surrounding Dentsply Sirona’s Byte aligners, I believe there is a significant risk to the company’s stock. Consequently, I see XRAY as a strong candidate for a short position in the near term.